Clinical trial

Uracil and Tegafur/Leucovorin (UFT/LV) Versus UFT/LV+ Polysaccharide-K (PSK) for…

NCT00497107 · Iwate Medical University, Other · Unknown status

Key facts

NCT number NCT00497107
Title Uracil and Tegafur/Leucovorin (UFT/LV) Versus UFT/LV+ Polysaccharide-K (PSK) for Stage IIIa/IIIb Colorectal Cancer
Official title Phase III Randomized Controlled Clinical Study of UFT/LV Therapy Versus UFT/LV + PSK Therapy as Postoperative Adjuvant Therapy for Histological Stage IIIa and IIIb Colorectal Cancer
Acronym ICOG
Lead sponsor Iwate Medical University, Other
Status Unknown status
Phase Phase 3
Study type Interventional
Conditions Colorectal Cancer
Intervention type Drug
Interventions UFT, Calcium Folinate, PSK
Enrollment 300
Start date Jul 1, 2007
Completion May 1, 2013
First posted Jul 6, 2007
Last update posted Jul 31, 2008
Countries Japan

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies